- Location
abiraterone acetate
"-
Johnson & Johnson Has Completed The Acquisition of Aragon Pharmaceuticals
Aug 22, 2013Johnson & Johnson has completed the acquisition of Aragon Pharmaceuticals, a pharmaceutical discovery and development company focused on drugs to hormonally-driven cancers. The Janssen Research & Development will manage compound ...
-
EC Has Approved Broader Indication of Janssen-Cilag International's Oral
Jan 15, 2013The European Commission (EC) has approved broader indication of Janssen-Cilag International's oral, once-daily medication Zytiga (abiraterone acetate). Licence extension includes the use of Zytiga as a combination therapy along with ...
Tags: Zytiga, Janssen Europe, medical
-
Janssen Research and Development Has Received The Priority Review
Aug 30, 2012Janssen Research and Development has received the Priority Review for the supplemental New Drug Application (sNDA) for ZYTIGA from US Food and Drug Administration (FDA). Zytiga (abiraterone acetate) is administered in combination with ...
Tags: sNDA, priority review, FDA
-
Janssen Research Submitted a Supplemental New Drug Application to FDA for Zytiga
Jun 18, 2012Janssen Research & Development has announced that it has submitted a supplemental New Drug Application to FDA for ZYTIGA(abiraterone acetate). Janssen-Cilag International NV has also sent a type II variation to the European Medicines ...
Related Products
-
Good Quality API 99% CAS 154229-18-2 Abiraterone Acetate Powder
-
Best Price Pharmaceutical API Raw Materials Purity Abiraterone Acetate Powder CAS 154229-18-2
-
Pharmaceutical Chemicals High Purity Abiraterone Acetate CAS 154229-18-2
-
Pharmaceutical Intermediate Abiraterone Acetate Powder CAS 154229-18-2
-
High Quality Abiraterone Acetate Powder CAS 154229-18-2 Pharmaceutical Raw Material
-
High Purity API Abiraterone Acetate Powder CAS 154229-18-2 Cure Prostate Cancer
